Improving patient communication in gynecologic oncology
ASk Questions in GYnecologic Oncology (ASQ-GYO): A Randomized Controlled Trial of a Question Prompt List Communication Intervention in Outpatient Gynecologic Oncology Clinics
This study tests if a new list of questions can help women with gynecologic cancers feel more confident, less stressed, and build better trust with their doctors during their first visits.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 70 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Barbara Ann Karmanos Cancer Institute Academic / other |
| Locations | 1 site (Detroit, Michigan) |
| Trial ID | NCT06339827 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to evaluate the effectiveness of the ASk Questions in GYnecologic Oncology question prompt list (ASQ-GYO QPL) in enhancing patient self-efficacy, reducing distress, and increasing physician trust and knowledge during initial visits for gynecologic cancers. Participants will be randomized to receive either the usual care or the ASQ-GYO QPL intervention, which they will receive before their appointment. Surveys will be conducted before and after the visit to assess the impact of the intervention on patient experiences and outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have a biopsy-confirmed diagnosis of gynecologic cancer or concerning imaging/laboratory findings.
Not a fit: Patients with a diagnosis of dysplasia only or those who have previously discussed treatment with a Gynecologic Oncologist may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could empower patients with gynecologic cancers to communicate more effectively with their healthcare providers.
How similar studies have performed: Other studies have shown that structured communication tools can improve patient outcomes, suggesting that this approach may be beneficial.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years of age * Understands spoken and written English * Able to consent to study participation * Biopsy confirmed gynecologic cancer diagnosis (ovarian, endometrial, cervical, vulvar, or vaginal cancer or Gestational Trophoblastic Disease) OR have imaging and/or laboratory findings highly concerning for a cancer diagnosis and have not seen a Gynecologic Oncologist Exclusion Criteria: * pathologic diagnosis of dysplasia only (cervical, vulvar, or endometrial) * History and/or imaging/laboratory findings more indicative of a non-cancer diagnosis * Previous treatment discussion with a Gynecologic Oncologist
Where this trial is running
Detroit, Michigan
- Barbara Ann Karmanos Cancer Institute — Detroit, Michigan, United States (Recruiting)
Study contacts
- Principal investigator: Ira Winer, MD PhD — Barbara Ann Karmanos Cancer Institute
- Study coordinator: Ira Winer, MD PhD
- Email: iwiner@med.wayne.edu
- Phone: 3135769194
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.